Obesity

Obesity was linked to an increased breast cancer recurrence risk among postmenopausal women with hormone receptor-positive early-stage breast cancer who were treated with aromatase inhibitors, researchers reported in JAMA Network Open.

DALLAS — Adults with obesity and a genetic mutation that causes deficiency in the melanocortin-4 receptor (MC4R) pathway lost a similar amount of weight with tirzepatide as adults without a genetic mutation, according to a speaker.

DALLAS — In this Healio video exclusive, Ania M. Jastreboff, MD, PhD, highlights several medications that may have a large impact on obesity care in the near future.

BOSTON — After years of failed clinical trials with agents to lower severely elevated triglycerides, emerging therapeutics hold promise for effectively addressing hypertriglyceridemia and reducing associated CV risks, a speaker reported.

DALLAS — Adults with overweight or obesity receiving tirzepatide have a decrease in appetite, food craving and other eating behaviors, according to a speaker at ObesityWeek.

A recent study underscored the importance of the quality of carbohydrates in long-term weight management — particularly in those with excessive body weight, researchers said.

BOSTON — In this Healio video exclusive, Donna H. Ryan, MD, and Christopher Still, DO, FACP, discuss the optimal treatment strategy for patients who require weight loss beyond diet and lifestyle changes.

DALLAS — Oral semaglutide improves HbA1c and may prevent progression to type 2 diabetes for adults with prediabetes, according to a speaker at ObesityWeek.

DALLAS — In this Healio video exclusive, Michael S. Irwig, MD, discusses how gender-confirming hormone therapy may affect obesity and cardiometabolic health.

DALLAS — New data presented at ObesityWeek demonstrate an encouraging early profile of an investigational dual GLP-1/GIP receptor agonist in healthy adults, according to a speaker at ObesityWeek.